TG Therapeutics
TGTX
TGTX
109 hedge funds and large institutions have $293M invested in TG Therapeutics in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.1% less ownership
Funds ownership: 51.74% → 50.63% (-1.1%)
30% less capital invested
Capital invested by funds: $422M → $293M (-$129M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
109
Holding in Top 10
–
Calls
$5.56M
Puts
$3.98M
Top Buyers
| 1 | +$27M | |
| 2 | +$4.03M | |
| 3 | +$2.48M | |
| 4 |
Goldman Sachs
New York
|
+$2.38M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.66M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$12.3M | |
| 3 | -$8.29M | |
| 4 |
CCI
Columbus Circle Investors
|
-$8.1M |
| 5 |
BM
Bridger Management
New York
|
-$7.41M |